Summary
We determined plasma methocarbamol concentrations over 24 h following a 1.5 g methocarbamol dose (off-dialysis day) to 8 chronic haemodialysis patients and compared these results to those from 17 healthy male volunteers.
The harmonic mean elimination half-life was similar between the two groups, 1.24 and 1.14 h, respectively. tmax and the weight-adjusted Cmax were 1.1 h and 27.0 mg · m−1 for haemodialysis patients and 1.1 and 23.1 mg · l−1 for normals. Relative systemic availability was assessed by comparing weight-normalized AUC × k10 products.
These results indicate no significant differences with respect to methocarbamol absorption, with the relative systemic availability in patients being 113%.
These data suggest that absorption and elimination of methocarbamol is similar between normal subjects and patients undergoing maintenance haemodialysis.
References
Bruce RB, Turnbull LB, Newman JH (1971) Metabolism of methocarbamol in the rat, dog, and human. J Pharm Sci 60: 104–106
Gibson TP (1986) Renal disease and drug metabolism: An overview. Am J Kidney Dis 8: 7–17
Quintanilla AP (1986) Liver dysfunction in dialysis patients. Int J Artif Intern Organs 9: 1–2
Simon P, Meyrier A, Brissot P (1981) Uremia and the liver. II. Drugs and the liver in the uremic patient. Nephron 29: 7–13
Verbeeck RK (1982) Glucuronidation and disposition of drug glucuronides in patients with renal failure. A review. Drug Metab Disp 10: 87–89
Wagner JG (1967) Method of estimating relative absorption of a drug in a series of clinical studies in which blood levels are measured after single and/or multiple doses. J Pharm Sci 56: 652–653
Wagner JG (1978) Fundamentals of clinical pharmacokinetics. Drug Intelligence Publications, Hamilton, pp 347–348
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sica, D.A., Comstock, T.J., Davis, J. et al. Pharmacokinetics and protein binding of methocarbamol in renal insufficiency and normals. Eur J Clin Pharmacol 39, 193–194 (1990). https://doi.org/10.1007/BF00280060
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00280060